Jumping into metabolic medication support without a workup is a common telehealth failure mode: appetite changes without knowing baseline insulin dynamics, muscle loss risk ignored, thyroid or sex-hormone drivers of weight left unchecked, and side-effect monitoring improvised after the fact.
KAYU Health takes the opposite stance. Metabolic workup first. Educational pages on this hub stay non-branded—we discuss GLP support as a clinical category and care process, not as a product push for specific prescription brand names.
California residents only. Named clinicians: Narine Chilyan, DNP, AGNP-C · Dr. Aram Mkhitarian, DO. Membership is care pricing; pharmacy is separate at cost.
Risks of skipping the workup
Without labs and history, teams cannot distinguish:
- Primary lifestyle gap vs insulin resistance patterns
- Thyroid contribution to weight or energy
- Sex-hormone drivers (e.g., perimenopause shifts, low testosterone) that change the plan
- Contraindications or caution flags that should pause or redirect care
- Baseline values needed to judge whether a protocol is helping or harming
A quiz can sort intent. It cannot replace metabolic and hormone-aware labs.
Markers we commonly clarify
Individual orders vary. A serious metabolic-oriented workup often considers:
- Glycemic markers such as fasting glucose and HbA1c (/science/labs/hba1c)
- Fasting insulin / insulin-resistance context when indicated
- Lipid context
- Thyroid gatekeepers (e.g., TSH) when symptoms overlap
- Sex-hormone markers when history points to TRT or BHRT adjacency
- Safety labs appropriate to the pathway under consideration
See also /glp1/labs-before-glp-support and the hormone–weight bridge /glp1/hormones-and-weight.
When hormones drive weight
Weight is not only “calories in, calories out” in a vacuum. Perimenopause can redistribute fat and disrupt sleep. Low testosterone can reduce muscle and training drive. Thyroid dysfunction can flatten metabolism and energy. Treating weight as a standalone SKU while ignoring those axes is how people cycle through short-term appetite changes without durable metabolic health.
KAYU’s OS connects /hormones, /bhrt, /trt, and /glp1 so clinicians can route honestly.
California eligibility
You must be a California resident and able to complete telehealth visits under state rules. Intake must be accurate. Labs must be obtainable. If metabolic support is not appropriate—or another specialty should lead—we will say so rather than force a funnel.
Membership vs medication costs
Consult $49.99 opens the clinical conversation. Root $199, Branch $499, and Canopy $799 are care memberships with different follow-up intensity. Any medication costs are pharmacy-separate and billed at cost outside membership ARR. Educational content here does not promote specific brand-name injectables; compliance gates (including LegitScript → Google Healthcare) govern when branded product messaging may appear elsewhere on site.
What good looks like
- Clarify goals (weight, energy, cardiometabolic risk, hormone symptoms).
- Complete metabolic ± hormone labs as directed.
- Review with a named California clinician.
- Decide fit: lifestyle-first, hormone pathway, metabolic support, combination—or referral.
- If care proceeds, choose membership depth and monitoring cadence.
Start with /quiz (weight branch) or /book. Read the hub overview at /glp1.
Muscle, appetite, and why baselines matter
When appetite drops, protein intake and resistance training often need deliberate protection. Without baseline labs and a body-composition-aware plan, people can lose weight that includes muscle they wanted to keep. Workup-first care creates room to discuss those tradeoffs before—not after—a protocol begins.
Similarly, gastrointestinal tolerability, hydration, and constipation risk deserve monitoring language even on educational pages that stay non-branded. “Support” implies follow-up, not a set-and-forget shipment mindset.
Bridging to hormone hubs without forcing a product
If perimenopause is loud, send readers to /bhrt. If low-T symptoms dominate in men, send them to /trt. If both weight and hormones are unclear, the consult is the router. KAYU would rather diagnose the driver than win a single-SKU conversion.
A California patient’s first two weeks on this path
Week one: quiz or consult, history, medication reconciliation, goal setting (weight, A1c context, energy, joint comfort, muscle preservation). Week two: labs drawn as directed, including glycemic markers and other indicated tests. Results return to a named clinician—Narine Chilyan, DNP, AGNP-C or Dr. Aram Mkhitarian, DO—not an anonymous queue. Only then does the conversation turn to whether metabolic support belongs in the plan, whether hormones should lead, or whether lifestyle-first is the safer opening move.
If you already tried a medication elsewhere without labs, say so. Prior adverse effects, rapid muscle loss, or gallbladder symptoms change monitoring priorities. Bring discharge summaries if you have them. This is educational, not a complete safety label—your clinician reviews risks for your situation.
What “non-branded” means in practice on this URL
Use category language: GLP support, metabolic medication support, appetite-pathway therapies as a class. Do not push specific consumer brand names in H1, title, primary CTA, or body CTAs. Science namespace pages may discuss mechanisms separately; this hub child converts on workup-first care, not on a brand keyword war. Internal links should prefer `/glp1/`, `/hormones`, and `/science/labs/` over any branded promotional landing.
Questions worth asking in your consult
What markers are you ordering and why? How will we protect muscle if appetite falls? When would you pause or refer? How is pharmacy billed relative to Root, Branch, or Canopy? How do hormone findings change the plan? Clear answers to those questions are a better buying signal than any before/after montage.
KAYU’s stance is intentionally boring in the best way: workup, judgment, monitoring, California accountability. Start when ready via /book or /quiz.